IP Library Granted Patent US 9,222,685
Granted Patent B2
US 9,222,685 · App. 12/836,606 · Granted Dec 29, 2015

Method and system for controlling evaporative and heat withdrawal performance of an occupant support surface

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,222,685
App. No.
12/836,606
Granted
Dec 29, 2015
Kind
B2
Abstract

A method for controlling performance of an MCM capable support surface having a flowpath for guiding a stream of air along at least a portion of the surface, comprises specifying a desired evaporative rate greater than an evaporative rate achievable with unconditioned ambient air, chilling the unconditioned ambient air to a temperature at least as low as that required to achieve 100% relative humidity, thereby demoisturizing the air, and supplying the chilled, demoisturized air to the flowpath. The method may also include the step of heating the chilled, demoisturized air prior to step of supplying it to the flowpath. A system for carrying out the method includes a microclimate management (MCM) capable support surface 22 , a chiller 60 for cooling air to be delivered to the MCM capable surface, a user interface 42 for receiving instructions concerning desired microclimate management performance, and a controller 50 , responsive to the instructions, for operating the chiller.

Claims (33)

1. A method for controlling performance of an MCM capable support surface having a flowpath for guiding a stream of air along at least a portion of the surface, comprising:

measuring the temperature of the skin of a patient positioned on the surface;

receiving an input indicative of a desired evaporative rate greater than an evaporative rate achievable with unconditioned ambient air;

chilling unconditioned ambient air to a temperature at least as low as that required to achieve 100% relative humidity, thereby demoisturizing the air;

receiving an input indicative of a desired total heat withdrawal rate less than a total heat withdrawal rate achievable with the chilled air;

adding heat to the demoisturized air without adding moisture to the demoisturized air, the amount of heat added being based on the temperature of the skin of the patient; and

supplying the heated and demoisturized air to the flowpath to achieve the desired evaporation rate and the desired total heat withdrawal rate.

2. The method of claim 1 comprising determining a microclimate performance parameter and determining the heat to be added to the demoisturized air based on the microclimate performance parameter and on the temperature of the skin of the patient.

3. The method of claim 2 wherein the microclimate performance parameter is:

the ratio of the total heat withdrawal attributable to the chilled, demoisturized air and the total heat withdrawal achievable with the unconditioned ambient air.

4. The method of claim 1 comprising determining if the total heat withdrawal rate of the chilled, demoisturized air is unsatisfactorily high; and

carrying out the heating step only if the total heat withdrawal rate of the chilled air is determined to be unsatisfactorily high.

5. The method of claim 2 wherein the microclimate performance parameter is the difference in total heat withdrawal attributable to the chilled, demoisturized air and the total heat withdrawal achievable with the unconditioned ambient air.

6. The method of claim 2 wherein the microclimate performance parameter is the ratio of the dry flux attributable to the chilled, demoisturized air and the dry flux achievable with the unconditioned ambient air.

7. The method of claim 2 wherein the microclimate performance parameter is the ratio of the wet flux attributable to the chilled, demoisturized air and the wet flux achievable with the unconditioned ambient air.

8. The method of claim 2 wherein the microclimate performance parameter is the difference in wet flux attributable to the chilled, demoisturized air and the wet flux achievable with the unconditioned ambient air.

9. The method of claim 2 wherein the microclimate performance parameter is the ratio of the evaporative rate attributable to the chilled, demoisturized air and the evaporative rate achievable with the unconditioned ambient air.

10. The method of claim 2 wherein the microclimate performance parameter the difference in evaporative rate attributable to the chilled, demoisturized air and the evaporative rate achievable with the unconditioned ambient air.

11. A method for controlling performance of an MCM capable support surface having a flowpath for guiding a stream of air along at least a portion of the surface, comprising:

measuring the temperature of the skin of a patient positioned on the surface;

chilling the unconditioned ambient air to a temperature at least as low as that required to achieve 100% relative humidity, thereby demoisturizing the air;

receiving an input indicative of a desired total heat withdrawal rate less than a total heat withdrawal rate achievable with the chilled air;

adding heat to the demoisturized air without adding moisture to the demoisturized air, the amount of heat added being based on the temperature of the skin of the patient; and

supplying the heated and demoisturized air to the flowpath to achieve the desired total heat withdrawal rate.

12. The method of claim 11 comprising determining a microclimate performance parameter and determining the heat to be added to the demoisturized air based on the microclimate performance parameter and on the temperature of the skin of the patient.

13. The method of claim 12 wherein the microclimate performance parameter the ratio of the total heat withdrawal attributable to the chilled, demoisturized air and the total heat withdrawal achievable with the unconditioned ambient air.

14. The method of claim 12 wherein the microclimate performance parameter is the difference in total heat withdrawal attributable to the chilled, demoisturized air and the total heat withdrawal achievable with the unconditioned ambient air.

15. The method of claim 12 wherein the microclimate performance parameter is the ratio of the dry flux attributable to the chilled, demoisturized air and the dry flux achievable with the unconditioned ambient air.

16. The method of claim 12 wherein the microclimate performance parameter is the ratio of the wet flux attributable to the chilled, demoisturized air and the wet flux achievable with the unconditioned ambient air.

17. The method of claim 12 wherein the microclimate performance parameter is the difference in wet flux attributable to the chilled, demoisturized air and the wet flux achievable with the unconditioned ambient air.

18. The method of claim 12 wherein the microclimate performance parameter is the ratio of the evaporative rate attributable to the chilled, demoisturized air and the evaporative rate achievable with the unconditioned ambient air.

19. The method of claim 12 wherein the microclimate performance parameter the difference in evaporative rate attributable to the chilled, demoisturized air and the evaporative rate achievable with the unconditioned ambient air.

20. The method of claim 11 comprising determining if the total heat withdrawal rate of the chilled, demoisturized air is unsatisfactorily high; and carrying out the heating step only if the total heat withdrawal rate of the chilled air is determined to be unsatisfactorily high.

Assignments (7)
RELEASE OF SECURITY INTEREST AT REEL/FRAME 050260/0644 Recorded Dec 14, 2021
From: JPMORGAN CHASE BANK, N.A.
To: BREATHE TECHNOLOGIES, INC.; HILL-ROM SERVICES, INC.; ALLEN MEDICAL SYSTEMS, INC.; WELCH ALLYN, INC.; HILL-ROM, INC.; VOALTE, INC.; BARDY DIAGNOSTICS, INC.; HILL-ROM HOLDINGS, INC.
Reel/Frame 058517/0001 →
SECURITY AGREEMENT Recorded Sep 4, 2019
From: HILL-ROM HOLDINGS, INC.; HILL-ROM, INC.; HILL-ROM SERVICES, INC.; ALLEN MEDICAL SYSTEMS, INC.; ANODYNE MEDICAL DEVICE, INC.; VOALTE, INC.; WELCH ALLYN, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 050260/0644 →
RELEASE OF SECURITY INTEREST Recorded Sep 3, 2019
From: JPMORGAN CHASE BANK, N.A.
To: HILL-ROM SERVICES, INC.; ALLEN MEDICAL SYSTEMS, INC.; WELCH ALLYN, INC.; HILL-ROM COMPANY, INC.; HILL-ROM, INC.; ANODYNE MEDICAL DEVICE, INC.; MORTARA INSTRUMENT, INC.; MORTARA INSTRUMENT SERVICES, INC.; VOALTE, INC.
Reel/Frame 050254/0513 →
SECURITY AGREEMENT Recorded Sep 26, 2016
From: HILL-ROM SERVICES, INC.; ASPEN SURGICAL PRODUCTS, INC.; ALLEN MEDICAL SYSTEMS, INC.; WELCH ALLYN, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 040145/0445 →
SECURITY INTEREST Recorded Sep 10, 2015
From: ALLEN MEDICAL SYSTEMS, INC.; HILL-ROM SERVICES, INC.; ASPEN SURGICAL PRODUCTS, INC.; WELCH ALLYN, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 036582/0123 →
CHANGE OF STATE OF INCORPORATION FROM DELAWARE TO INDIANA Recorded Dec 18, 2013
From: HILL-ROM SERVICES, INC. (DELAWARE CORPORATION)
To: HILL-ROM SERVICES, INC. (INDIANA CORPORATION)
Reel/Frame 031837/0085 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2010
From: LACHENBRUCH, CHARLES A
To: HILL-ROM SERVICES, INC.
Reel/Frame 024793/0807 →